Expression of CDX2 in metastatic prostate cancer

The intestinal marker CDX2 has recently been found to stain a small percentage of primary prostate adenocarcinomas, but little is known of its expression in metastatic prostate cancers. We present a case of metastatic prostate adenocarcinoma that stained for CDX2 and highlight the confusion this may...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrieri, C., Jobbagy, Z., Hudacko, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2019
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138494/
https://www.ncbi.nlm.nih.gov/pubmed/31748757
http://dx.doi.org/10.32074/1591-951X-19-19
_version_ 1783695822553088000
author Guerrieri, C.
Jobbagy, Z.
Hudacko, R.
author_facet Guerrieri, C.
Jobbagy, Z.
Hudacko, R.
author_sort Guerrieri, C.
collection PubMed
description The intestinal marker CDX2 has recently been found to stain a small percentage of primary prostate adenocarcinomas, but little is known of its expression in metastatic prostate cancers. We present a case of metastatic prostate adenocarcinoma that stained for CDX2 and highlight the confusion this may create when evaluating a carcinoma of unknown primary.
format Online
Article
Text
id pubmed-8138494
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Pacini Editore srl
record_format MEDLINE/PubMed
spelling pubmed-81384942021-07-08 Expression of CDX2 in metastatic prostate cancer Guerrieri, C. Jobbagy, Z. Hudacko, R. Pathologica Letter to Editor The intestinal marker CDX2 has recently been found to stain a small percentage of primary prostate adenocarcinomas, but little is known of its expression in metastatic prostate cancers. We present a case of metastatic prostate adenocarcinoma that stained for CDX2 and highlight the confusion this may create when evaluating a carcinoma of unknown primary. Pacini Editore srl 2019-09-01 /pmc/articles/PMC8138494/ /pubmed/31748757 http://dx.doi.org/10.32074/1591-951X-19-19 Text en © 2019 Copyright by Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Letter to Editor
Guerrieri, C.
Jobbagy, Z.
Hudacko, R.
Expression of CDX2 in metastatic prostate cancer
title Expression of CDX2 in metastatic prostate cancer
title_full Expression of CDX2 in metastatic prostate cancer
title_fullStr Expression of CDX2 in metastatic prostate cancer
title_full_unstemmed Expression of CDX2 in metastatic prostate cancer
title_short Expression of CDX2 in metastatic prostate cancer
title_sort expression of cdx2 in metastatic prostate cancer
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138494/
https://www.ncbi.nlm.nih.gov/pubmed/31748757
http://dx.doi.org/10.32074/1591-951X-19-19
work_keys_str_mv AT guerrieric expressionofcdx2inmetastaticprostatecancer
AT jobbagyz expressionofcdx2inmetastaticprostatecancer
AT hudackor expressionofcdx2inmetastaticprostatecancer

Ejemplares similares